HealthMore in Health→
ASCO Abstract Drop Signals a New Round in Oncology’s Data Race
Key Takeaways
- ASCO’s abstract drop is highlighting several high-stakes oncology races.
- The supplied text points to interest in VEGF bispecifics, TROP2 ADCs and post-Ibrance strategies.
- Conference data remains tightly linked to biotech valuation and deal activity.
DE
DT Editorial Team··via endpoints.news
